KIMBERLY KOONTZ: Open Payments
NPI 1205235355 · SAINT PETERS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 65 payments from 17 companies in 2025. Trend: 2023 $14 · 2024 $223 · 2025 $1,142
Food & beverage: $1,142
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $278 |
| Lilly USA, LLC | 9 | $160 |
| Novo Nordisk Inc | 10 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $144 |
| PFIZER INC. | 5 | $84 |
| Exact Sciences Corporation | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Boston Scientific Corporation | 1 | $34 |
| Amgen Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
Products named: VRAYLAR, XIFAXAN, MOUNJARO, Wegovy, NURTEC ODT, Cologuard Collection Kit, SHINGRIX, QULIPTA.
Industry payments across MO — which companies pay providers there.
